- Home
- CPRX vs NHI Comparison
CPRX vs NHI Comparison
Compare CPRX & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | NHI |
|---|---|---|
| Founded | 2002 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | 2006 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CPRX | NHI |
|---|---|---|
| Price | $31.45 | $77.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $35.00 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 1.7M | 617.2K |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.81% |
| EPS Growth | ★ 28.24 | N/A |
| EPS | 0.50 | ★ 0.82 |
| Revenue | $119,072,803.00 | ★ $375,628,000.00 |
| Revenue This Year | $9.20 | $15.44 |
| Revenue Next Year | $10.51 | $10.01 |
| P/E Ratio | ★ $62.94 | $94.45 |
| Revenue Growth | ★ 16.39 | 12.07 |
| 52 Week Low | $19.05 | $67.94 |
| 52 Week High | $32.56 | $91.38 |
Technical Indicators
Market Signals| Indicator | CPRX | NHI |
|---|---|---|
| Relative Strength Index (RSI) | 71.22 | 60.85 |
| Support Level | $31.25 | $76.15 |
| Resistance Level | $32.56 | $77.80 |
| Average True Range (ATR) | 0.04 | 1.66 |
| MACD | -0.09 | 0.96 |
| Stochastic Oscillator | 70.59 | 87.25 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
About NHI National Health Investors Inc.
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.